ENVALITH
フランスベッドホールディングス株式会社 logo

FRANCE BED HOLDINGS CO.,LTD.

7840・Prime Market・Other Products

Official website
フランスベッドホールディングス株式会社 logo
FRANCE BED HOLDINGS CO.,LTD.7840

Business

France Bed Holdings is a corporate group operating as a holding company with 8 consolidated subsidiaries, 2 non-consolidated subsidiaries, and 2 affiliated companies. In its core Medical Service business, the company centers on the rental and sale of welfare equipment under the long-term care insurance system, while also engaging in bed sales for hospitals and elderly care facilities, and linen supply services. In the Interior Health business, the company manufactures, wholesales, and conducts door-to-door sales of beds, furniture, bedding, and health equipment. Its main customers span a wide range, including home care service users, care managers, hospitals, hotels, and general consumers. Consolidated net sales for FY2026 (ending March 2026) were ¥61,769 million. The Medical Service business accounts for approximately 68% of sales and serves as the group's growth engine.

Business Model

In the core Welfare Equipment Rental Business, monthly rental fee income utilizing the long-term care insurance system forms stable, recurring revenue. Through customer acquisitions (assuming rental contracts from competitors facing business succession issues), the company has expanded its rental contract base, achieving growth that exceeds the market growth rate. In the Interior Health business, revenue is secured by combining manufacturing and wholesale of mid-to-high-priced, high-value-added products with hotel rentals. Investment in rental assets is funded through sale-and-leaseback arrangements, with operating cash flow allocated to shareholder returns and working capital.

Company Strengths

In the core Welfare Equipment Rental Business, rental sales expanded beyond the market growth rate through the promotion of customer transfers. Medical Service segment sales for FY2026 (ending March 2026) reached ¥41,830 million (up 3.2% year on year), and under the management policy of aiming to become the No.1 domestic welfare equipment rental operator, the company continues to hire sales staff, expand its delivery vehicle fleet, and enhance service centers.

The Product Development Department and Sleep Research Center of France Bed Co., Ltd. lead research and development, with R&D expenses of ¥207 million in FY2026 (ending March 2026). The company practices product development based on its proprietary quality standard, the "FES Standard," and has successively launched new products including the industry's first Eco Mark-certified mattress "Hotel Eco Collection," the snoring-reduction pillow "Sirea," and the bed-embedded monitoring system "M-2R."

The equity ratio as of the end of FY2026 (ending March 2026) was 59.2% (improved from 57.2% at the end of the previous fiscal year). Cash and cash equivalents stood at ¥12,355 million, and operating cash flow generated was ¥6,333 million. Financial expenses have been reduced through centralized management of group funds via CMS (Cash Management Service), and the company has the financial strength to cover rental asset investment, shareholder returns, and working capital needs with its own funds.

ENVALITH's Perspective

In FY2026 (ending March 2026), net sales increased to ¥61,769 million (up 1.9% year on year), but operating profit fell to ¥4,335 million (down 7.7% year on year) and net income attributable to owners of parent fell to ¥2,746 million (down 6.8% year on year), marking a second consecutive year of profit decline. Higher personnel expenses associated with wage increases, soaring logistics costs, and upfront investment aimed at expanding the Medical Service business pushed up SG&A expenses (SG&A expenses of ¥29,478 million, up ¥1,119 million year on year). As external factors, price inflation and elevated personnel costs continue, making improvement of the cost structure an urgent priority.

Sales in the Medical Service business grew steadily to ¥41,830 million (up 3.2% year on year), but segment ordinary profit declined to ¥3,369 million (down 6.2% year on year), reflecting a lower profit margin. While the structural tailwind of the baby boomer generation entering late-stage elderly age continues in the market environment, upfront investment costs such as hiring sales staff, expanding the delivery vehicle fleet, and building out service centers are weighing on profit. In the Linen Supply Business, temporary costs arose in the second quarter due to tight laundry processing capacity, but it is worth noting that profitability turned to an improving trend from the third quarter onward.

Sales in the Interior Health business were ¥19,380 million (down 0.5% year on year), and segment ordinary profit was ¥952 million (down 10.7% year on year), reflecting continued difficult conditions. As an external factor, sluggish demand for durable consumer goods amid ongoing price inflation is directly impacting sales to furniture stores and event-based sales. On the other hand, the effects of structural reform measures decided in the current period, such as factory reorganization (business structure improvement expenses of ¥78 million recorded as extraordinary loss), are expected to materialize from the next fiscal year onward, and progress on initiatives aimed at improving profitability in FY2027 (ending March 2027) will be a focus of attention.

Growth Strategy

Aiming for a return to profit growth through concentrating resources on the silver business and improving the earnings structure

In addition to the continuous succession of welfare equipment rental contracts through the customer transfer scheme, the company is promoting the strengthening of its organizational structure and enhancing service center functions to expand rentals, particularly in urban areas. In FY2026 (ending March 2026), multiple projects including large-scale contract successions were implemented, achieving sales of ¥41,830 million (up 3.2% year on year).

Based on the plan to consolidate and reorganize production sites, the company implemented reductions in manufacturing and logistics costs, optimization of inventory management, and a review of the cost structure. In FY2026 (ending March 2026), business structure improvement expenses of ¥78 million were recorded as extraordinary losses, with profitability improvement effects expected to materialize from the following period onward.

The company is promoting sales of IoT sensor-equipped beds and related IoT equipment to hospitals and elderly care facilities. Orders are increasing on the back of the expansion of subsidies for the introduction of care technology. Future product development is also progressing, with the multifunctional care bed (tentative name), which has transfer assistance functions, having been selected for AMED support.

The company is promoting fixed cost reductions through reviewing business processes and consolidating functions in indirect departments, including the head office division. In FY2027 (ending March 2027), rather than prioritizing sales expansion, the company will focus on improving its earnings structure, forecasting operating profit of ¥4,600 million (up 6.1% year on year), ordinary profit of ¥4,700 million (up 8.3% year on year), and net income attributable to owners of parent of ¥3,070 million (up 11.7% year on year).

Last updated: July 19, 2026